Small (Weinheim an der Bergstrasse, Germany)

Lipid nanoparticles that restore iron supply and use RNA interference to trigger iron-dependent cell death for cancer treatment

Updated

Abstract

ALSF, a novel lipid nanoparticle, enabled effective co-delivery of GPX4-siRNA and Fe3+ for cancer treatment.

  • The lipid nanoparticle replaces DSPC with arachidonic acid to facilitate simultaneous delivery.
  • ALSF promotes acid- and H2O2-dependent iron recycling to generate Fe2+, enhancing reactive oxygen species production.
  • Silencing of GPX4 by siRNA leads to increased lipid peroxidation and induction of ferroptosis.
  • Elevated H2O2 levels in cancer cells enhance iron recycling and aid in siRNA escape from lysosomes.
  • In vivo experiments showed that ALSF suppressed tumor growth in a C918 xenograft model while demonstrating favorable biosafety.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free